Background: Severe tricuspid regurgitation, constrictive pericarditis and restrictive cardiomyopathy can all present with signs and symptoms of right heart failure and similar haemodynamic findings of ...
Eosinophil-mediated endomyocardial damage is a well-known complication in patients with hypereosinophilic syndromes (HES). Although management and survival have improved significantly, some patients ...
Correspondence to: Ramachandran S Vasan, MD, Framingham Heart Study, 73, Mt Wayte Avenue, Framingham, MA 01702, USA; vasan{at}fram.nhlbi.nih.gov ...
Original research: Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial (9 September, ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Correspondence to Prof Hugh Tunstall-Pedoe, Cardiovascular Epidemiology Unit, Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, UK; ...
2 The National Center for Chronic and Noncommunicable Disease Control and Prevention, Beijing, China Objective To examine cardiovascular disease (CVD) mortality burden attributable to ambient ...
Atrial fibrillation (AF) is a common arrhythmia associated with increased risk of stroke, heart failure and mortality. Advances in genomic research have revealed a complex genetic architecture ...
Objective To describe patterns of prehospital ECG (PHECG) use and determine its association with processes and outcomes of care in patients with ST-elevation myocardial infarction (STEMI) and ...
Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation
Objective Severe secondary tricuspid regurgitation (STR) causes significant right atrial (RA) volume overload, resulting in structural and functional RA-remodelling. This study evaluated whether ...
Developments in artificial intelligence (AI) have led to an explosion of studies exploring its application to cardiovascular medicine. Due to the need for training and expertise, one area where AI ...
Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results